Xiangrui Bio is an independent innovative technology enterprise integrating R&D, production and sales of preventive biological products and in vivo diagnostic reagents. The company’s main products are meningococcal vaccines and in vivo diagnostic reagents. Recently, Xiangrui Bio was listed on the New Third Board.
This article is reproduced from: https://www.itjuzi.com/investevent/13523519
This site is for inclusion only, and the copyright belongs to the original author.